We’re thrilled to announce a collaboration with our companions at Melanoma Analysis Alliance to convey a curated expertise to sufferers and caregivers impacted by melanoma. In the USA, melanoma is without doubt one of the commonest varieties of most cancers, and its prevalence has tripled in latest many years. It’s estimated that 100,000 individuals will probably be identified with invasive melanoma every year, and greater than 1.4 million individuals at present reside with the situation.
MRA is the world’s largest nonprofit funder of melanoma analysis and has been a member of the Antidote companion community since 2017. By way of ongoing collaboration, we now have applied vital enhancements to their website’s Scientific Trial Navigator powered by Antidote Match. The platform enhancements embrace a person move tailor-made to particular person responses, expanded capabilities addressing questions on uncommon melanoma subtypes, inquiries about earlier and forthcoming therapies and therapies, and nuanced enter choices for people in earlier illness phases.
These developments underscore Antidote and MRA’s unwavering dedication to enhancing the medical trial search expertise for sufferers and caregivers impacted by melanoma. By prioritizing user-centric design and performance, the Scientific Trial Navigator goals to make the method of discovering related medical trials extra environment friendly and tailors the expertise to the particular wants of sufferers and their care companions. To expertise this course of, go to curemelanoma.org/clinicaltrials now.